SCHEMBL844902

SCHEMBL844902

CN(C)CC(=O)N1CCC[C@H]1C(=O)Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)CN(C)C)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
NPC1 O15118 1/20 0.46
PABPC1 P11940 1/20 0.45
HTT P42858 2/20 0.45
MAPK1 P28482 2/20 0.45
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
LMNA P02545 2/20 0.43
GAA P10253 1/20 0.43
KDM4E B2RXH2 1/20 0.43
TSHR P16473 1/20 0.43
EP300 Q09472 1/20 0.42
CREBBP Q92793 1/20 0.42
CCR1 P32246 1/20 0.42
HCRTR1 O43613 1/20 0.42
HCRTR2 O43614 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL844961 0.89 RHOC (0.43) ALDH1A1CYP2C9CYP2C19NPC1PABPC1
SCHEMBL844967 0.88 MAPK1 (0.50) ALDH1A1CYP2C9CYP2C19PABPC1HTT
SCHEMBL845251 0.87 PABPC1 (0.50) ALDH1A1CYP2C9CYP2C19NPC1PABPC1
SCHEMBL845253 0.85 VHL (0.43) ALDH1A1CYP2C9CYP2C19MEN1KMT2A
SCHEMBL13272388 0.85 VHL (0.43) ALDH1A1CYP2C9CYP2C19MEN1KMT2A
SCHEMBL845228 0.85 HCRTR1 (0.49) ALDH1A1CYP2C9CYP2C19NPC1PABPC1
SCHEMBL844899 0.85 NPC1 (0.52) ALDH1A1CYP2C9CYP2C19NPC1PABPC1
SCHEMBL845774 0.84 CYP2C19 (0.49) ALDH1A1CYP2C9CYP2C19NPC1PABPC1
SCHEMBL845203 0.84 CCR1 (0.47) ALDH1A1CYP2C9CYP2C19NPC1PABPC1
SCHEMBL845245 0.84 PTPN1 (0.50) ALDH1A1CYP2C9CYP2C19NPC1PABPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed